A Phase 1 Mass Balance Study of TS-172 in Healthy Adult Subjects
Latest Information Update: 08 Oct 2024
At a glance
- Drugs TS-172 (Primary)
- Indications Hyperphosphataemia
- Focus Pharmacokinetics
- Sponsors Taisho Pharmaceutical
- 02 Oct 2024 Status changed from not yet recruiting to recruiting.
- 30 Sep 2024 New trial record